The Role of Clinical Trials in Preclinical Alzheimer’s Disease Drug Development Programs

被引：0
|
作者：
Jeffrey Cummings
机构：
[1] University of Nevada Las Vegas,Department of Brain Health, School of Integrated Health Sciences
[2] Cleveland Clinic Lou Ruvo Center for Brain Health,undefined
来源：
The Journal of Prevention of Alzheimer's Disease | 2020年 / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：288 / 290
页数：2
相关论文
共 50 条
  • [31] Preclinical and clinical challenges in the development of disease-modifying therapies for Alzheimer's disease
    Scorer, CA
    DRUG DISCOVERY TODAY, 2001, 6 (23) : 1207 - 1219
  • [32] Role of meta-analysis of clinical trials for Alzheimer's disease
    Arrieta, JML
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (03) : 401 - 411
  • [33] PREVENTIVE DRUG TRIALS FOR ALZHEIMER'S DISEASE
    Vellas, Bruno
    NEUROBIOLOGY OF AGING, 2014, 35 : S23 - S24
  • [34] The role of biomarkers in clinical trials for Alzheimer disease
    Thal, LJ
    Kantarci, K
    Reiman, EM
    Klunk, WE
    Weiner, MW
    Zetterberg, H
    Galasko, D
    Praticò, D
    Griffin, S
    Schenk, D
    Siemers, E
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2006, 20 (01): : 6 - 15
  • [35] An update on EHT 0202 preclinical and clinical development for Alzheimer's Disease therapy
    Desire, L.
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2009, 2009, : 29 - 32
  • [36] An Industry Perspective on Intervention Trials in Preclinical Alzheimer's Disease
    Egan, Michael
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S18 - S19
  • [37] The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials
    Sperling, Reisa
    Mormino, Elizabeth
    Johnson, Keith
    NEURON, 2014, 84 (03) : 608 - 622
  • [38] Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights
    Dharmini C. Mehta
    Jennifer L. Short
    Sarah N. Hilmer
    Joseph A. Nicolazzo
    Pharmaceutical Research, 2015, 32 : 819 - 839
  • [39] Drug Access to the Central Nervous System in Alzheimer's Disease: Preclinical and Clinical Insights
    Mehta, Dharmini C.
    Short, Jennifer L.
    Hilmer, Sarah N.
    Nicolazzo, Joseph A.
    PHARMACEUTICAL RESEARCH, 2015, 32 (03) : 819 - 839
  • [40] Phytochemicals in Alzheimer disease: The development of clinical trials
    Quinn, J
    Kaye, J
    Montine, T
    Stackman, R
    PHARMACEUTICAL BIOLOGY, 2004, 42 : 64 - 73
12345